In this episode, Bob examines Google Maps' latest advancements in AI-powered 3D mapping and route optimization, highlighting their potential to revolutionize navigation. The episode then delves into the AI-driven partnership between Insilico Medicine and Eli Lilly, showcasing the growing trend of AI in pharmaceutical collaborations. Bob explores the broader rise of AI in these collaborations, emphasizing their impact on drug discovery and development. The discussion shifts to the complex realm of AI-driven drone warfare, addressing technological advancements, ethical considerations, and potential global impacts. The episode concludes with a sign-off, wrapping up the day's AI insights.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related